BMS Expands CAR-T Therapy Capabilities with Strategic $380 Million Investment in Cellares

BMS, Bristol Myers Squibb, Cellares, CAR-T therapy, cell therapy, cancer treatment, biotechnology, investment, capacity expansion, manufacturing, automation.

The Transformative Future of Specialist Distribution: Adaptive Strategies and Technological Innovations

Specialist Distribution, Future Trends, Adaptive Strategies, Technological Innovations, Automation, Artificial Intelligence, Last-Mile Solutions, Virtual Distribution, Data Integration, Global Expansion, Smart Distribution Centers